October 14, 2015

Today's Top Alzheimer's News

USA2 SPOTLIGHT

An October 13, 2015 MarketWatch release highlighted the work of The Global CEO Initiative on Alzheimer's Disease (CEOi) and announced that Axovant Sciences joined the group convened by UsAgainstAlzheimer's. According to Vivek Ramaswamy, CEO and founder of Axovant, “As a leading clinical-stage company dedicated to developing novel therapies for patients with dementia, we are thrilled to partner with George and the CEO initiative to help deliver meaningful improvements to Alzheimer's disease patients and their caregivers. We share the organization's commitment to driving innovation and bringing new solutions to the problem of Alzheimer's disease.”


MUST READS

An October 14, 2015 The Wall Street Journal article profiled a contentious legal battle focused on Alzheimer’s research. According to the article, “Caught in the crossfire of the legal dispute is the Alzheimer’s Disease Collaborative Study, a $100 million-plus research effort to test new drugs, formed between the University of California, San Diego and the National Institute on Aging, a federal agency, and partly funded by corporate grants from companies like Eli Lilly & Co. Neither the companies nor the NIH are named as defendants.”

An October 14, 2015 The Courier-Journal article reported on the high costs of caregiving for the elderly. According to the article, “Once they can no longer be trusted to handle their medications or meals on their own, some outside care is needed, but Lewis said round-the-clock care can be necessary for five to eight years. At a median annual cost of $91,250 for a private nursing home room, according to Genworth Financial's 2015 Cost of Care study, that can add up to $456,250 for five years and $730,000 for eight. In fact, long-term care of all sorts could break almost anyone's bank.”

An October 13, 2015 PR Newswire release highlighted new survey data from the Alzheimer’s Association that finds voters prioritize Alzheimer’s. According to the data, “73 million voters, or one-third of all voters, have had a family member or close friend with Alzheimer's disease…The majority, 64 percent, of voters would be more likely to vote for a presidential candidate who has pledged to support a major national research effort to fight Alzheimer’s.”